Skip to main content
. 2023 Nov 22;17(1):65–82. doi: 10.1007/s40271-023-00657-4

Table 4.

Summary scores by sociodemographic and clinical characteristics

n EQ-TIPS LSS n Y-3L LSS n EQ-TIPS/Y-3L %LSS EQ VAS PedsQL total score PTHSI %
Total Median (IQR) 66 7 (6, 9) 77 7 (5, 10) 143 40 (33.3, 63.9) 90 (70, 100) (76.6 (57.7, 87.1) 80.0 (66.7, 86.7)
Age groups
1–12 months Median (IQR) 20 6 (6, 8) 20 33.3 (33.3, 41.7) 87.5 (73, 100) 83 (74.5, 92.8) 93.3 (86.7, 93.3)
13–24 months Median (IQR) 12 8 (6, 12) 12 44.4 (33.3, 66.7) 87.0 (55.0, 100.0) 74.3 (53.9, 82.8) 93.3 (76.7, 96.7)
2–4 years Median(IQR) 34 7 (6, 11) 34 38.9 (33.3, 61.1) 90.0 (80.0, 100.0) 77.2 (59.2, 90.9) 80.0 (66.7, 86.7)
5–7 years Median (IQR) 28 6 (5, 8) 28 40.0 (33.3, 53.3) 95 (80, 100) 76.6 (57.3, 86.1) 80 (70, 87)
8–12 years Median (IQR) 26 8 (6, 11) 26 53.3 (40.0, 73.3) 84 (60, 100) 52.9 (33.8, 57.7) 80 (40, 87)
13–18 years Median (IQR) 23 10 (6, 11) 23 66.7 (40.0, 73.3) 80 (70, 97) 47.9 (38.5, 64.8) 60 (47, 80)
Kruskal–Wallis H test (p-value) 3.35 (p = 0.187) 12.1 (p = 0.002) 20.13 (p = 0.001) 3.37 (p = 0.643) 16.2 (p = 0.006) 33.93 (p < 0.001)
Gender
Female Median (IQR) 25 7 (6, 8) 32 7 (5, 11) 57 38.9 (33.3, 53.3) 90 (70, 100) 77.9 (62.6, 87.1) 80 (66.7, 86.7)
Male Median (IQR) 41 7 (6, 11) 45 8 (6, 10) 86 46.7 (933.3, 66.7) 90 (73, 100) 70.7 (55.0, 91.1) 80 (66.7, 86.7)
Mann–Whitney U test (p-value) 545.0 (p = 0.651) 1.08 (p = 0.300) 2851.5 (p = 0.136) 2701.0 (p = 0.389) 1086 (p = 0.262) 2488.5 (p = 0.982)
Technology for breathing
Non-invasive ventilation Median (IQR) 5 8 (7, 9) 21 9 (8, 11) 26 56.7 (46.7, 73.3) 80 (70, 95) 66.5 (48.8, 77.9) 80 (60, 86.7)
Tracheostomy Median (IQR) 51 7 (6, 11) 47 6 (5, 9) 98 38.9 (33.3, 60.0) 90 (70, 100) 76.8 (59.6, 91.1) 80 (66.7, 86.7)
Tracheostomy and ventilation Median (IQR) 9 7 (6, 9) 9 10 (6, 11) 19 46.7 (33.3, 73.3) 90 (80, 100) 78.1 (57.7, 83.1) 66.7 (46.7, 86.7)
Kruskal–Wallis H test (p-value) 0.841 (p = 0.840) 8.92 (p = 0.012) 9.65 (p = 0.008) 2.51 (p = 0.286) 1.78 (p = 0.411) 2.84 (p = 0.242)
Clinical severity
Mild Median (IQR) 56 7 (6, 9) 62 6 (5, 9) 117 40.0 (33.3, 53.3) 90 (70, 100) 76.6 (59.6, 87.1) 80 (66.7, 86.7)
Moderate Median (IQR) 9 9 (6, 14) 15 11 (10, 12) 25 66.7 (50.0, 80.0) 85 (70, 100) 65.4 (46.8, 83.9) 80 (46.7, 93.3)
Kruskal–Wallis H test (p-value 1.86 (p = 0.394) 19.42 (p < 0.001) 15.18 (p < 0.001) 2.30 (p = 0.317) 2.48 (p = 0.290) 1.51 (p = 0.470)
Clinical prognosis
Good, technology likely permanent Median (IQR) 12 9 (7, 14) 29 9 (6, 11) 42 60.0 (38.9, 73.3) 83 (70, 100) 58.8 (50.0, 77.7) 80 (60, 86.7)
Long survival, weaning possible Median (IQR) 35 6 (6, 7) 27 6 (5, 9) 62 33.3 (33.3, 50.0) 93 (70, 100) 78.1 (67.4, 89.9) 80 (66.7, 86.7)
Poor, survival unlikely beyond a year Median (IQR) 2 8 (6, 9) 1 9 (9, 9) 3 50.0 (33.3, 60.0) 90 (45, 100) 78..9 (77.2, 80.5) 93.3 (80.0, 100.0)
Kruskal–Wallis H test (p-value 14.09 (p = 0.003) 4.07 (p = 0.254) 14.67 (p = 0.002) 1.86 (p = 0.603) 5.33 (p = 0.149) 3.39 (p = 0.335)

LSS level sum score, PedsQL Pediatric Quality of Life Inventory, PTHSI Paediatric Tracheostomy Health Status Instrument, VAS Visual Analogue Scale